Cargando…

Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma

Exosomes, the cell-derived small extracellular vehicles, play a vital role in intracellular communication by reciprocally transporting DNA, RNA, bioactive protein, chains of glucose, and metabolites. With great potential to be developed as targeted drug carriers, cancer vaccines and noninvasive biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Hong, Zhang, Hao, Mao, Jinning, Cao, Hui, Tao, Yihao, Zhao, Guanjian, Zhang, Zhiwen, Zhang, Nan, Liu, Zaoqu, Zhang, Jian, Luo, Peng, Xia, Yuguo, Cheng, Yuan, Xie, Zongyi, Cheng, Quan, Liu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070666/ https://www.ncbi.nlm.nih.gov/pubmed/37012233 http://dx.doi.org/10.1038/s41419-023-05753-9

Ejemplares similares

The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial
por: Sun, Maoyuan, et al.
Publicado: (2022)

Advances in technology and applications of nanoimmunotherapy for cancer
por: Dou, Lei, et al.
Publicado: (2021)

Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
por: Kumari, Nisha, et al.
Publicado: (2022)

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis
por: Zhang, Hao, et al.
Publicado: (2023)

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
por: Lameijer, Marnix, et al.
Publicado: (2018)

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Peng, Lu, et al.
Publicado: (2021)

Exosomal circRNAs as promising liquid biopsy biomarkers for glioma
por: Wu, Xiaoke, et al.
Publicado: (2023)

Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas
por: Zhang, Hao, et al.
Publicado: (2022)

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
por: Zhang, Nan, et al.
Publicado: (2022)

Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas
por: Xiao, Gelei, et al.
Publicado: (2022)

Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas
por: Anagnostakis, Filippos, et al.
Publicado: (2023)

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
por: Zhang, Hao, et al.
Publicado: (2023)

Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype
por: Qi, Yiwei, et al.
Publicado: (2023)

AQP9 Is a Prognostic Factor for Kidney Cancer and a Promising Indicator for M2 TAM Polarization and CD8+ T-Cell Recruitment
por: Jing, Jibo, et al.
Publicado: (2021)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients
por: Peng, Zhigang, et al.
Publicado: (2020)

Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
por: Chen, Rui, et al.
Publicado: (2022)

Molecular mechanism of CD163(+) tumor-associated macrophage (TAM)-derived exosome-induced cisplatin resistance in ovarian cancer ascites
por: Zhang, Xiaohui, et al.
Publicado: (2022)

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
por: Lin, Anqi, et al.
Publicado: (2022)

Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer
por: Lin, Anqi, et al.
Publicado: (2023)

Crystal structure of the BAZ2B TAM domain
por: Feng, Yingying, et al.
Publicado: (2022)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Comprehensive analysis of pyroptosis‐related gene signatures for glioblastoma immune microenvironment and target therapy
por: Wang, Zeyu, et al.
Publicado: (2023)

Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
por: Niu, Zhiyuan, et al.
Publicado: (2017)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis
por: Rui, Tao, et al.
Publicado: (2022)

IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression
por: Chen, Hao, et al.
Publicado: (2022)

Exosomes Derived from Glioma Cells under Hypoxia Promote Angiogenesis through Up-regulated Exosomal Connexin 43
por: Yang, Zhang-Jian, et al.
Publicado: (2022)

Helicobacter pylori infection reduces TAMs infiltration in a mouse model of AOM/DSS induced colitis-associated cancer
por: Li, Luo-na, et al.
Publicado: (2020)

The TAM-TB Assay—A Promising TB Immune-Diagnostic Test With a Potential for Treatment Monitoring
por: Ahmed, Mohamed I. M., et al.
Publicado: (2019)

Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma
por: Zhang, Hao, et al.
Publicado: (2022)

Diversification of TAM receptor function
por: Zagórska, Anna, et al.
Publicado: (2014)

Targeting the TAM Receptors in Leukemia
por: Huey, Madeline G., et al.
Publicado: (2016)

DICERing macrophages for reprogramming TAMs
por: Squadrito, Mario Leonardo, et al.
Publicado: (2016)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

TAM Signaling in the Nervous System
por: Burstyn-Cohen, Tal, et al.
Publicado: (2021)

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
por: Shi, Congqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ed6pd4k5rr0ijhti635i3jvkae